Extendicare - EXETF Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$15.75
▲ +0.74 (4.93%)

This chart shows the closing price for EXETF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Extendicare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EXETF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EXETF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Extendicare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $15.75.

This chart shows the closing price for EXETF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 polled investment analysts is to moderate buy stock in Extendicare. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/4/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/4/2025National BanksharesReiterated RatingOutperform ➝ Outperform
12/4/2025Royal Bank Of CanadaUpgradeSector Perform ➝ Outperform
12/4/2025BMO Capital MarketsUpgradeMarket Perform ➝ Outperform
11/14/2025TD SecuritiesReiterated RatingHold ➝ Hold
9/22/2025CIBCInitiated CoverageOutperform
8/11/2025BMO Capital MarketsReiterated RatingMarket Perform ➝ Market Perform
5/20/2025Royal Bank Of CanadaReiterated RatingSector Perform ➝ Sector Perform
5/12/2025BMO Capital MarketsReiterated RatingMarket Perform ➝ Market Perform
3/5/2025Royal Bank Of CanadaReiterated RatingSector Perform ➝ Sector Perform
5/9/2023National Bank FinancialBoost TargetC$7.00 ➝ C$7.50
5/9/2023Royal Bank Of CanadaBoost TargetC$7.00 ➝ C$7.50
1/30/2023National Bank FinancialLower TargetC$7.50 ➝ C$7.00
11/17/2022Royal Bank Of CanadaLower TargetC$8.00 ➝ C$7.50
10/24/2022National Bank FinancialLower TargetC$8.00 ➝ C$7.50
3/3/2022Royal Bank Of CanadaBoost TargetC$8.00 ➝ C$8.50
2/7/2022TD SecuritiesInitiated CoverageHold
11/15/2021Royal Bank Of CanadaLower TargetSector PerformC$8.50 ➝ C$8.00
11/8/2021TD SecuritiesLower TargetHoldC$8.50 ➝ C$8.00
8/11/2021National Bank FinancialLower TargetSector Perform ➝ Sector PerformC$9.00 ➝ C$8.50
7/19/2021National Bank FinancialBoost TargetSector PerformC$8.50 ➝ C$9.00
5/14/2021TD SecuritiesBoost TargetHoldC$7.00 ➝ C$8.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2025
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2025
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/5/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/4/2025
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/4/2025

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Extendicare logo
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
Read More

Today's Range

Now: $15.75
Low: $15.14
High: $15.75

50 Day Range

MA: $12.74
Low: $10.24
High: $36.80

52 Week Range

Now: $15.75
Low: $6.72
High: $15.75

Volume

492 shs

Average Volume

13,500 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

8.00%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Extendicare?

The following Wall Street sell-side analysts have issued stock ratings on Extendicare in the last year: BMO Capital Markets, CIBC, National Bankshares, Inc., Royal Bank Of Canada, and TD Securities.
View the latest analyst ratings for EXETF.

What is the current price target for Extendicare?

0 Wall Street analysts have set twelve-month price targets for Extendicare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Extendicare in the next year.
View the latest price targets for EXETF.

What is the current consensus analyst rating for Extendicare?

Extendicare currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for EXETF.

What other companies compete with Extendicare?

How do I contact Extendicare's investor relations team?

Extendicare's physical mailing address is 3000 Steeles Avenue East, Markham, ON L3R. The company's listed phone number is (905) 470-4000. The official website for Extendicare is www.extendicare.com. Learn More about contacing Extendicare investor relations.